Gastrointestinal intolerance and bleeding with non-narcotic analgesics
- PMID: 3552587
- DOI: 10.2165/00003495-198600324-00007
Gastrointestinal intolerance and bleeding with non-narcotic analgesics
Abstract
Aspirin and paracetamol (acetaminophen) are the most commonly used minor analgesics, but their effects on the gastrointestinal tract differ widely. The effects of other nonsteroidal anti-inflammatory drugs (NSAIDs), including phenylbutazone, are intermediate. Aspirin is significantly associated with major upper gastrointestinal haemorrhage, whereas paracetamol is not. Short term use of aspirin produces erythema, erosions and occasionally ulcers; paracetamol does not, while other NSAIDs do so to varying degrees. Chronic gastric ulcer is linked to aspirin intake in patients with rheumatic disease, and epidemiologically in all heavy aspirin users. In only one epidemiological study was a paradoxical significant association reported between paracetamol intake and chronic gastric ulcer. Faecal occult blood loss is increased in most regular aspirin users but not in those taking paracetamol. Although formal studies in children have apparently not been made, in isolated small clinical series it has been reported that gastrointestinal bleeding and anaemia do occur in the paediatric age group after the use of aspirin. Pathophysiologically, aspirin alters the gastric mucosal barrier to hydrogen ions and lowers gastric potential difference; paracetamol has no effect on these parameters. Such changes correlate ultrastructurally with damage in surface epithelial cells and microerosions after the use of aspirin, but not after the use of paracetamol. Aspirin and other NSAIDs cause a dramatic reduction in the ability of gastric mucosa to generate protective prostaglandins; however, paracetamol also reduces prostaglandins. Other postulated mechanisms of aspirin damage include reduction in gastric mucosal secretion, reduction in bicarbonate output, and alteration of cell turnover. Because damage to gastric mucosa by aspirin and NSAIDs is often 'silent', the clinician needs a high level of suspicion and awareness regarding this problem. In patients prone to gastric damage, or in those with a past history of aspirin-induced gastric damage, paracetamol is the drug of choice when a minor, non-inflammatory problem requires an analgesic.
Similar articles
-
Gastrointestinal effects of antipyretic analgesics.Am J Med. 1983 Nov 14;75(5A):53-64. doi: 10.1016/0002-9343(83)90233-4. Am J Med. 1983. PMID: 6359868 Review.
-
Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Actions of therapeutic agents.Am J Med. 1988 Feb 22;84(2A):41-8. doi: 10.1016/0002-9343(88)90253-7. Am J Med. 1988. PMID: 2894763 Review.
-
Drugs, gastritis, and peptic ulcer.J Clin Gastroenterol. 1981;3(Suppl 2):29-34. J Clin Gastroenterol. 1981. PMID: 7320467
-
Gastrointestinal toxicity of minor analgesics.Br J Clin Pharmacol. 1980 Oct;10 Suppl 2(Suppl 2):407S-410S. doi: 10.1111/j.1365-2125.1980.tb01831.x. Br J Clin Pharmacol. 1980. PMID: 7002193 Free PMC article. Review.
-
NSAID-induced gastric mucosal damage.Am Fam Physician. 1987 Jun;35(6):101-8. Am Fam Physician. 1987. PMID: 3332745 Review.
Cited by
-
Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice.Dig Dis Sci. 1998 Mar;43(3):447-58. doi: 10.1023/a:1018895417831. Dig Dis Sci. 1998. PMID: 9539636 Review.
-
Pharmacokinetics of common analgesics, anti-inflammatories and antipyretics in children.Clin Pharmacokinet. 1989;17 Suppl 1:116-37. doi: 10.2165/00003088-198900171-00009. Clin Pharmacokinet. 1989. PMID: 2692935 Review.
-
Die Salicylate.Schmerz. 1990 Sep;4(3):166-72. doi: 10.1007/BF02527883. Schmerz. 1990. PMID: 18415257 German. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous